MEDP

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 Current Total common shares outstanding 28.74 M28.09 M28.17 M28.38 M28.56 M 28.56 M Enterprise value 8.32 B8.77 B14.2 B15.44 B13.06 B 14.29 B Price to earnings ratio 23.2623.3435.9636.7630.22 32.92 Price to sales ratio 4.54.46.696.555.3 5.69 Price to cash flow ratio 16.6816.0422.1623.2519.23 20.59 Price to book ratio 3.174.028.5136.129.27 10 Enterprise value to EBITDA ratio 17.0517.2526.4227.4322.05 24.15 Return on assets % 0.060.060.060.070.06 0.06 Return on equity % 0.190.520.380.290.21 0.21 Return on invested capital % 23.8919.5123.1727.8225.08 25.08 Gross margin % 31.9329.8429.8428.9827.78 27.78 Operating margin % 20.3220.9421.4921.6320.03 20.03 EBITDA margin % 21.5622.1422.6322.7421 21 Net margin % 20.5214.9616.8419.0717.53 17.53 Quick ratio ————— — Current ratio 0.730.430.570.740.85 0.85 Inventory turnover ————— — Asset turnover 0.280.350.40.380.34 0.34 Debt to assets ratio ————— — Debt to equity ratio ————— — Long term debt to total assets ratio ————— — Long term debt to total equity ratio ————— — Operating cash flow per share 4.035.18.546.525.24 25.41 EBIT per share 3.644.344.925.194.89 19.33 EBITDA per share 3.864.585.185.465.12 20.35 Total debt per share ————— — Cash per share 14.151.599.916.8322.54 22.54 Net current asset value per share 26.3317.8725.5933.5239.33 39.33 Tangible book value per share 19.035.9110.1915.5520.66 20.66 Working capital per share -9.64-24.01-18.97-11.99-7.11 -7.11 Book value per share 19.035.9110.1915.5520.66 20.66